FOLD vs TECH
Amicus Therapeutics Inc (FOLD) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Amicus Therapeutics Inc (FOLD) is a biotechnology company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported FOLD revenue for 2024-12-31 was $528.3M. Net income was -$56.1M. Revenue was up 32.3% from 2023-12-31 to 2024-12-31. FOLD currently screens at market cap $1.80B.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
FOLD currently screens at market cap $1.80B. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the FOLD and TECH stock pages for the full models.
Not investment advice.